Medical News

RSS

Positive results from Diamyd Medical's NP2 Enkephalin Phase I trial for chronic pain

Substantial and sustained reduction in pain scores were reported in the middle and high dose cohorts of Diamyd Medical's Phase I, open-label, dose escalation trial investigating NP2 Enkephalin as a potential therapy for chronic pain. No treatment related Serious Adverse Events have been observed in the study to date.

19 Oct 2010

Shift in agriculture techniques required to ensure future food security, U.N. special rapporteur on right to food says on World Food Day

Farming techniques must adapt to mitigate the effects of climate change and ensure global food security, Olivier De Schutter, the U.N. special rapporteur on the right to food, said in a statement to mark Saturday's World Food Day, Agence France-Presse reports.

19 Oct 2010

Moderate amount of protein in low-carb beverage improves aerobic endurance: Report

Compared to a standard carbohydrate supplement, a low-carbohydrate beverage with added protein leads to longer endurance times in cyclists, reports the October issue of the The Journal of Strength and Conditioning Research, official research journal of the National Strength and Conditioning Association.

19 Oct 2010

60 Plus applauds FDA decision to remove unapproved colchicine products

James L. Martin, chairman of the 60 Plus Association, a seniors advocacy group, applauded the Food and Drug Administration's (FDA) decision to remove unapproved colchicine products from the market, and called on drug manufacturers, distributors and pharmacies to help the FDA protect patients from unapproved drugs.

19 Oct 2010

Novartis announces six-year data of Reclast injection for postmenopausal women with osteoporosis

Novartis announced today that new six-year data reinforce the long-term efficacy and safety profile of once-yearly Reclast (zoledronic acid) injection in postmenopausal women with osteoporosis.The study of more than 1,200 women was presented this weekend at the annual meeting of the American Society for Bone and Mineral Research (ASBMR) in Toronto, ON, Canada.

19 Oct 2010

Chemicals in everyday substances increase risk of allergies in children

The use of chemicals in our everyday lives entails increased risks of allergies in children, according to a study at Karlstad University in Sweden. The prevalence of PGEs, propylene glycol and glycol ethers, in bedroom air is associated with asthma, hay fever, and eczema, but also with antibodies against common allergens in children. The study shows a risk increase of up to 180 percent.

19 Oct 2010

MPI of Biochemistry and GSK collaborate in development of new drugs for type 2 diabetes

The recently signed cooperation agreement between the MPI of Biochemistry and GSK pursues the objective of developing innovative new drugs. The joint research and development work is based on the research findings of Axel Ullrich, Director at the MPI of Biochemistry.

19 Oct 2010

6th Decade of the Mind Conference to be held in Singapore

A total of 15 world renowned cognitive scientists have been invited to share recent advances in their respective fields at the 6th Decade of the Mind Conference to be held at Fusionopolis from 18 - 20 October 2010. Jointly organised by A*STAR's Institute of High Performance Computing (IHPC), MINDEF's Defence Research & Technology Office (DRTech) and NUS's Temasek Laboratories, it is the first such conference in Asia to promote awareness of Cognitive Science research done in Asia and from around the world.

19 Oct 2010

New website provides access to hospice care

Hospice Care of South Carolina, the largest hospice care provider in South Carolina, recently launched a new website designed to help people facing an advanced illness and their loved ones gain earlier access to hospice care.

19 Oct 2010

NIH awards contract to CSC for BTRIS, CRIS programs

CSC announced today that the National Institutes of Health (NIH) awarded the company a contract to provide support services to the Biomedical Translational Research Information System (BTRIS) and Clinical Research Information System (CRIS) programs.

19 Oct 2010

STOP-BANG questionnaire on sleep apnea syndrome helps identify patients' risk for surgical complication

A research team from the Jefferson Sleep Disorders Center at Thomas Jefferson University Hospital has utilized a simple, eight-item pre-operative questionnaire about obstructive sleep apnea syndrome that could help identify patients at risk for complications following surgery, according to a report in the October issue of Archives of Otolaryngology-Head & Neck Surgery, one of the JAMA/Archives journals. Individuals prone to the obstructive sleep apnea syndrome as determined by the questionnaire appear to have an increased risk of heart, lung and other complications following elective surgery.

19 Oct 2010

Long-term use of statins reduces colorectal cancer risk

A systematic review of the medical literature supports the hypothesis that statins, cholesterol-lowering drugs used to prevent cardiac problems, are associated with reduced risk of colon and rectal cancers.

19 Oct 2010

UC awarded $2.1 million technology award to develop next generation brain monitors

The U.S. Department of Defense has awarded researchers at the University of Cincinnati (UC) a $2.1 million Advanced Technology/Therapeutic Development Award to develop the next generation of brain monitors.

19 Oct 2010

Peer partner program helps diabetic patients to manage their conditions

Phone calls with a peer facing the same self-management challenges helped diabetes patients manage their conditions and improved their blood sugar levels better than those who used traditional nurse care management services alone, according to research from the University of Michigan Health System.

19 Oct 2010

Researchers discover how cocaine corrupts brains' reward center

Mount Sinai researchers have discovered how cocaine corrupts the brain and becomes addictive. These findings-the first to connect activation of specific neurons to alterations in cocaine reward-were published in Science on October 15. The results may help researchers in developing new ways of treating those addicted to the drug.

19 Oct 2010

Study investigates effectiveness of potential treatment for Non-alcoholic steatohepatitis

Estimates of the prevalence of liver disease suggest that one‐third of the United States population has non‐alcoholic fatty liver disease (NAFLD). NAFLD is now the most common cause for elevated liver function tests in the United States, a trend related to the obesity epidemic in this country. Non-alcoholic steatohepatitis (NASH), the progressive form of NAFLD, can lead to cirrhosis and all its complications.

19 Oct 2010

Discovery of 4 new DNA 'hotspots' may aid in developing new therapies for psoriasis

Scientists at the University of Michigan Heath System and their collaborators have found four new DNA "hotspots" that may one day help guide new treatments for psoriasis, one of the most common autoimmune diseases in the country.

19 Oct 2010

Study suggests epoD; microtubule-stabilizing drugs may treat neurodegenerative diseases

Finding a drug that can cross the blood-brain barrier is the bane of drug development for Alzheimer's disease and other neurological disorders of the brain. A new Penn study, published this week in the Journal of Neuroscience, has found and tested in an animal model of Alzheimer's disease a class of drug that is able to enter the brain, where it stabilizes degenerating neurons and improves memory and learning.

19 Oct 2010

New data on Merck’s odanacatib for osteoporosis in postmenopausal women presented at 32nd ASBMR

New data on odanacatib, an investigational cathepsin-K (Cat-K) inhibitor in development for the treatment of osteoporosis in postmenopausal women, were presented at the 32nd Annual Meeting of the American Society for Bone and Mineral Research (ASBMR) in Toronto, Canada.

19 Oct 2010

U.S. District Court issues decision in NPWT patent litigation

The U.S. District Court for the Western District of Texas has issued a decision in the patent litigation between Kinetic Concepts, Inc. Wake Forest University and Smith & Nephew, Inc. The Court held that the patent claims licensed by KCI from Wake Forest University and asserted in this litigation are invalid.

19 Oct 2010

Medical News

Positive results from Diamyd Medical's NP2 Enkephalin Phase I trial for chronic pain

Shift in agriculture techniques required to ensure future food security, U.N. special rapporteur on right to food says on World Food Day

Moderate amount of protein in low-carb beverage improves aerobic endurance: Report

60 Plus applauds FDA decision to remove unapproved colchicine products

Novartis announces six-year data of Reclast injection for postmenopausal women with osteoporosis

Chemicals in everyday substances increase risk of allergies in children

MPI of Biochemistry and GSK collaborate in development of new drugs for type 2 diabetes

6th Decade of the Mind Conference to be held in Singapore

New website provides access to hospice care

NIH awards contract to CSC for BTRIS, CRIS programs

STOP-BANG questionnaire on sleep apnea syndrome helps identify patients' risk for surgical complication

Long-term use of statins reduces colorectal cancer risk

UC awarded $2.1 million technology award to develop next generation brain monitors

Peer partner program helps diabetic patients to manage their conditions

Researchers discover how cocaine corrupts brains' reward center

Study investigates effectiveness of potential treatment for Non-alcoholic steatohepatitis

Discovery of 4 new DNA 'hotspots' may aid in developing new therapies for psoriasis

Study suggests epoD; microtubule-stabilizing drugs may treat neurodegenerative diseases

New data on Merck’s odanacatib for osteoporosis in postmenopausal women presented at 32nd ASBMR

U.S. District Court issues decision in NPWT patent litigation

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News